Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention
JW Basler, GA Piazza - The Journal of urology, 2004 - Elsevier
PURPOSE: There is increasing evidence that using nonsteroidal anti-inflammatory drugs
decreases the incidence of clinically apparent prostate cancer. We review the potential
mechanisms of cancer reduction with cyclooxygenase (COX)-2 inhibitors and the clinical
evidence suggesting their effectiveness. MATERIALS AND METHODS: A literature review
using MEDLINE was conducted of animal, observational, and clinical studies of nonsteroidal
anti-inflammatory drugs in cancer, specifically prostate cancer. The Physician Data Query …
decreases the incidence of clinically apparent prostate cancer. We review the potential
mechanisms of cancer reduction with cyclooxygenase (COX)-2 inhibitors and the clinical
evidence suggesting their effectiveness. MATERIALS AND METHODS: A literature review
using MEDLINE was conducted of animal, observational, and clinical studies of nonsteroidal
anti-inflammatory drugs in cancer, specifically prostate cancer. The Physician Data Query …